90%Confidence
0Views
FDASource
2026-03-14Date
Summary
FDA issues Class II recall for BioGlo Fluorescein Sodium Ophthalmic Strips due to sterility concerns from non-compliance with cGMP at Omni Lens. This signals potential supply disruptions for HUB Pharmaceuticals and raises quality control risks for ophthalmic products from this manufacturer.
Actionable: Monitor HUB Pharmaceuticals for potential stock impacts and consider alternative suppliers for fluorescein sodium strips.
AI Confidence: 90%
Data Points
firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productBioGlo Fluorescein Sodium Ophthalmic Strips USP, 100 diagnostic strips, Manufactured by Omni Lens PVT. Ltd., 5 - Samrudhhi, Opp. Sakar-III, Navrangpur
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now